This site uses cookies to make your web experience a great one.Learn More

The cookie settings on this website are currently set to allow certain types of cookies. We do not use cookies for targeted or behavioral advertising on this website. Those cookies that we do use are designed to permit you to use the site functions and browse our site in the way that is favorable to you. If you continue without changing your cookie settings, you consent to that. However, you can change your cookie setting at any time.

Avantage Dual Mobility Cup System

Avantage reload Vivacit-E_Ceramic1000x1000

12-16% of revision surgeries are due to dislocation6-8. In Europe it is estimated to cause suffering for 12,000 – 22,000 patients and €58M-€78M annually to healthcare providers9.   

Biomet introduced the Avantage system in 1998 to address patients with high risk of dislocation. Avantage is a dual mobility acetabular system combining a proprietary anatomical cup design and a unique ultra-low wear polyethylene. Since 2005, the Avantage system has been the N°1 cementless and cemented dual mobility cup on the market1.

The Avantage double mobility cup system is an optimal solution for the treatment of patients with a high risk of dislocation or recurrent dislocation10. Its anatomic design offers joint stability11 and a large range of motion12. From primary to more complex revision and reconstruction cases, the comprehensive Avantage double mobility system addresses most surgical needs.

  • Superior Cap helps reduce risk of superior dislocation
  • Anatomic aperture helps reduce risk of impingement and increases ROM
  • Flattened pole helps increase peripheral load
  • Smooth superior-inferior transition helps reduce soft tissue irritation
  • E1® Antioxidant Infused Polyethylene
  • 96.9% survival rate @ 9 years, National Joint Registry - England, Wales and NI2
  • 96.3% survival rate @ mean 7.2 years, Fresard et al, Multicentre Study3
  • 0.36% dislocation rate4
  • 10A (cementless) 5A (cemented) ODEP rating5
  1. Eucomed data reports. Period: 2005-2013
  2. NJR data extract, March 2014 – analysed by Biomet
  3. Danish Hip Arthroplasty Register, Annual Report, 2011
  4. Mukka, S. et al. Dual Mobility Cups for Preventing Early Hip Arthroplasty Dislocation in Patients at Risk: Experience in a County Hospital. Orthopedic Reviews (Pavia). 5(2): e10, 2013.
  5. https://www.odep.org.uk
  6. Swedish Hip Arthroplasty Registry (2012)
  7. National Joint Registry for England Wales and Northern Island, 10th Annual Report, 2013
  8. Danish Hip Arthroplasty Register, Annual Report, 2011
  9. Biomet Market Analysis
  10. Data on File at Biomet. Push-in /lever-out Avantage test report MT 5357 not necessarily indicative of clinical performance.
  11. Beaule, et al. Jumbo femoral head for the treatment of recurrent dislocation following total hip replacement.  J Bone Joint Surg February 2002; 84-A: 2, pp. 256–63.
  12. Burroughs BR, et al. Range of motion and stability in total hip arthroplasty with 28, 32, 38, and 44mm femoral head sizes: An in vitro study. The Journal of Arthroplasty, January 2005; Vol. 20, Issue 1, Pages 11-19.

 

Legal Manufacturer:                      

Biomet Orthopedics
56 East Bell Drive
P.O. Box 587 
Warsaw, Indiana 46581 USA


All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet.  
This material is intended for health care professionals.  Distribution to any other recipient is prohibited.
For product information, including indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert and information on this website.